Symbiotec Pharmalab Ltd share price logo

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC

BSE: 544889

Small Cap

₹1279.50

+24.60

(+1.96%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Symbiotec Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-57%

Searches for Symbiotec Pharma on INDmoney have decreased by 57% over the last 30 days.

Investment activity on INDmoney

-61.95%

Investment activity in Symbiotec Pharma among INDmoney users has decreased by 61.95% over the last 30 days.

Among the most traded stocks

201st

Symbiotec Pharma was the 201st most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

6 days

INDmoney investors hold Symbiotec Pharma shares for an average of 6 days.

Symbiotec Pharma Stock Performance

as on October 16, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,235.00
    ₹1,309.90
    downward going graph

    3.48%

    Downside

    2.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹934.20
    ₹1,309.90
    downward going graph

    26.99%

    Downside

    2.38%

    Upside

    downward going graph

Symbiotec Pharma share price movements today

Previous Close
₹1,254.90
Open
₹1,253.00
Volume
10.06L
Upper Circuit
₹1,505.80
Lower Circuit
₹1,004.00
Day's Low - High
₹1,235.00 - ₹1,309.90
52 Week Low - High
₹934.20 - ₹1,309.90

Symbiotec Pharma Historical Returns

1 Month Return
+ 16.84 %
3 Month Return
+ 16.56 %
1 Year Return
+ 16.56 %
3 Year Return
+ 16.56 %
5 Year Return
+ 16.56 %

Symbiotec Pharma Fundamentals

as on October 16, 2026 at 4:01 pm IST

Market Cap

₹8,221.57 Cr

Return on Equity (ROE)

-

PE Ratio (TTM)

-

Return on capital employed (ROCE)

-

Industry PE ratio

-

Beta (LTM)

-

P/B Ratio

-

Dividend Yield

-

PEG Ratio

-

Quarterly Earnings Growth YOY

0

EPS (TTM)

-

Book Value

0

Symbiotec Pharma Technical Analysis

Track how Symbiotec Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish1
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.24
Bearish
CCI (20)
-131.04
Bullish
RSI (14)
40.19
Neutral
Momentum (10)
-3.3
Bearish
ADI (14)
40.75
Bearish
Ultimate Oscillator (7,14,28)
48.15
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1277.16
Bearish
EMA (20)
1277.6
Bearish
VWMA (20)
1278.03
Bearish
SMA (50)
1276.95
Bearish
EMA (50)
1276.5
Bearish
SMA (200)
1273.49
Bearish
EMA (200)
1274.49
Bearish
KAMA (200)
1274.85
Bearish
DEMA (200)
1275.08
Bearish

Symbiotec Pharmalab Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Symbiotec Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA0.0040.17%0.00NA15
Zenith Drugs Ltd image
Zenith Drugs Ltd
NA69.62-12.28%0.009131
OneSource Specialty Pharma Ltd image
OneSource Specialty Pharma Ltd
BUY16,143.65-3.53%0.60-741,421
Ambalal Sarabhai Enterprises Ltd image
Ambalal Sarabhai Enterprises Ltd
NA289.603.84%0.6317202
Roopa Industries Ltd image
Roopa Industries Ltd
NA0.0025.9%0.002127
See all

Symbiotec Pharmalab Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2025
Mar 2026
Jun 2026
Sales
203.17
245.25
218.15
Other Income
2.64
0.16
0.34
Total Income
205.81
245.41
218.49
Expenses
145.21
183.16
172.95
Operating Profit
57.96
62.09
45.2
Operating Profit Margin %
28.53%
25.32%
20.72%
Profit Before Interest, Tax and Depreciation
60.61
62.25
45.54
Interest
5.28
7.26
6.18
Depreciation
10.51
19.75
21.82
Profit Before Tax
44.82
35.24
17.54
Tax Paid
14.9
7.71
3.47
Profit After Tax
29.92
27.53
14.06
Total Net profit including share of profit / Loss from associate company
29.92
27.53
14.06
EPS
5.37
4.78
2.24
Actual EPS
5.37
4.78
2.24
Adjusted EPS
5.37
4.78
2.24
Diluted EPS
5.34
4.76
2.24

Symbiotec Pharmalab Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
566.51
716.25
751.55
869.15
Other Income
6.46
7.09
4.43
3.11
Total Income
572.97
723.33
755.98
872.26
Expenses
498.72
546.29
549.87
640.29
Operating Profit
67.79
169.96
201.68
228.86
Operating Profit Margin %
11.97%
23.73%
26.84%
26.33%
Profit Before Interest, Tax and Depreciation
74.25
177.04
206.11
231.97
Interest
7.46
7.24
16.04
25.33
Depreciation
28.52
38.82
43.1
53.28
Profit Before Tax
38.27
130.98
146.97
153.36
Tax Paid
14.78
30.93
50.19
43.46
Profit After Tax
23.49
100.06
96.79
109.9
Total Net profit including share of profit / Loss from associate company
23.49
100.06
96.79
109.9
EPS
4.29
17.7
17.7
19.1
Actual EPS
4.29
17.7
17.7
19.1
Adjusted EPS
4.29
17.7
17.7
19.1
Diluted EPS
4.29
17.67
17.7
19

Symbiotec Pharmalab Ltd Cash Flow

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
41.6
24.64
23.01
87.74
174.33
17.71
69.24
187.5
47.26
174.59
Cash Flow from Investing Activities
-3.06
13.38
-12.59
-41.42
-96.35
-31.65
-219.98
-206.41
-306.52
-226.94
Cash Flow from Financing Activities
-44.18
-31.7
-14.19
-42.23
-79.28
15.14
146.14
21.84
278.17
35.98
Net Cash Flow
-5.62
6.32
-3.76
4.1
-1.3
1.21
-4.61
2.94
18.9
-16.35

Symbiotec Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2025
Aug 2026
Sep 2026
Promoters
35.07%
33.28%
33.28%
DII
0%
27.52%
33.17%
FII
0%
21.08%
3.79%
Public
0%
18.12%
29.76%
Total Outstanding Shares
6,16,81,496
6,42,56,112
6,42,56,112
Total Shareholders
15
4,27,730
81,747

Symbiotec Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Symbiotec Pharma.

  • Symbiotec Pharmalab Ltd Earnings Results

    Symbiotec Pharmalab Ltd’s net profit fell -53.01% since last year same period to ₹14.06Cr in the Q1 2026-2027. On a quarterly growth basis, Symbiotec Pharmalab Ltd has generated -48.89% fall in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Symbiotec Pharma Stock

Check stock indices that include Symbiotec Pharma.

BSE IPO

₹18,246.33

+66.64 (▲0.37%)

Insights on Symbiotec Pharmalab Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 0.00% to 18.12% in Aug 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SYMBIOTEC stock has moved up by 16.2%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.00% to 5.54% in Aug 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 2.68% in Aug 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 35.07% to 33.28% in Aug 2026 quarter

About Symbiotec Pharmalab Ltd

Symbiotec Pharmalab Private Limited was incorporated as a private limited company dated September 20 2002 with the Registrar of Companies Madhya Pradesh and Chhattisgarh. Subsequently the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26 2025 was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing. The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility. It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients API and Intermediates.The Company has a global leadership position in corticosteroid and steroidalhormone active pharmaceutical ingredients. With over 30 years of industry experience it has evolved from a labscale steroidalhormone API manufacturer in year 1995 into an industrialscale backwardintegrated platform with approvals from the United States Food and Drug Administration USFDA European Union Good Manufacturing Practices EUGMP Ministry of Food and Drug Safety Korea and other global organisations.The Company started production of APIs at the Rau Facility in year 2004 and later commenced the same including hormone synthesis at the Pithampur Facility in 2010. In 2012 it commissioned a 5 KL biotech plant at Pithampur and a 35 kilolitres KL fermentation project at the Pithampur Facility. The Company had two operational industrialscale API manufacturing facilities with a maximum chemical synthesis capacity of 584.67 metric tons and fermentation capacity of 300 kilolitres. It has commissioned two additional manufacturing facilities leading to an aggregate maximum chemical synthesis capacity of 584.67 MT maximum fermentation capacity of 700 KL and complex injectables capacity of 20 million vials per annum. The Company later expanded a sterile plant at the Rau Facility in 202223. It has commissioned a complex injectables facility at the Mhow and further installed a 400 KL at the Ujjain Plant in FY 2025. Company has filed a Draft Red Herring Prospectus with SEBI and is planning to raise funds through IPO aggregating to Rs 2180 crores consisting a fresh offer of Rs 150 crore and the offer for sale of Rs 2030 crores having the face value of Rs 2 each..

Revenue: ₹218.15Cr as on June 2026 (Q1 FY27)
Net Profit: ₹14.06Cr as on June 2026 (Q1 FY27)
Listing date: 01 Sep, 2026
OrganisationSymbiotec Pharmalab Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Symbiotec Pharma share price today?

Symbiotec Pharma share price today stands at ₹1279.5 as on at the close of the market. Symbiotec Pharma share today touched a day high of ₹1309.9 and a low of ₹1235.

What is the 52 week high and 52 week low range for Symbiotec Pharma share?

Symbiotec Pharma touched a 52 week high of ₹1309.9 and a 52 week low of ₹934.2. Symbiotec Pharma share price today i.e. is closed at ₹1279.5, which is -2.32% down from its 52 week high and 36.96% up from its 52 week low.

What is Symbiotec Pharma's market capitalisation today?

Symbiotec Pharma market capitalisation is ₹8,221.57 Cr as on .

How to buy Symbiotec Pharma shares?

To buy Symbiotec Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SYMBIOTEC or Symbiotec Pharmalab Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Symbiotec Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Symbiotec Pharma trading volume today?

Symbiotec Pharma trading volume is 10.06L as on . This means that 10.06L shares of Symbiotec Pharma were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Symbiotec Pharma shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Symbiotec Pharma have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 6 days. This reflects platform activity only and is not investment advice.